Compare ETFs: IBB vs. LON:BTEC
IBB
LON:BTEC
Comparison
Average Return
In the past year, IBB returned a total of 48.26%, which is significantly lower than LON:BTEC's 54.53% return. Over the past 5 years, IBB has had annualized average returns of 3.08%, compared to 5.41% for LON:BTEC. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.09% |
| 2 | AMGN | Amgen Inc. | 7.90% |
| 3 | GILD | Gilead Sciences, Inc. | 6.94% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.05% |
| 5 | ARGX | argenx SE | 3.73% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.15% |
| 7 | NTRA | Natera, Inc. | 2.87% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.74% |
| 9 | BIIB | Biogen Inc. | 2.39% |
| 10 | ILMN | Illumina, Inc. | 2.16% |
| 11 | INSM | Insmed Incorporated | 1.81% |
| 12 | UTHR | United Therapeutics Corporation | 1.80% |
| 13 | ONC | BeOne Medicines AG | 1.77% |
| 14 | MRNA | Moderna, Inc. | 1.75% |
| 15 | INCY | Incyte Corporation | 1.72% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.42% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.31% |
| 18 | ASND | Ascendis Pharma A/S | 1.31% |
| 19 | GMAB | Genmab A/S | 1.10% |
| 20 | EXEL | Exelixis, Inc. | 1.05% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.03% |
| 22 | MEDP | Medpace Holdings, Inc. | 0.97% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.95% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.90% |
| 25 | TECH | Bio-Techne Corporation | 0.89% |
| View IBB holdings | |||
| LON:BTEC - iShares NASDAQ US Biotechnology UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.14% |
| 2 | AMGN | Amgen Inc. | 7.94% |
| 3 | GILD | Gilead Sciences, Inc. | 6.99% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 4.62% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.83% |
| 6 | RVMD | Revolution Medicines, Inc. | 2.74% |
| 7 | BIIB | Biogen Inc. | 2.16% |
| 8 | ILMN | Illumina, Inc. | 1.94% |
| 9 | ARGX | argenx SE | 1.77% |
| 10 | ROIV | Roivant Sciences Ltd. | 1.77% |
| 11 | RPRX | Royalty Pharma plc | 1.75% |
| 12 | MRNA | Moderna, Inc. | 1.71% |
| 13 | UTHR | United Therapeutics Corporation | 1.67% |
| 14 | INSM | Insmed Incorporated | 1.64% |
| 15 | INCY | Incyte Corporation | 1.55% |
| 16 | GH | Guardant Health, Inc. | 1.37% |
| 17 | VTRS | Viatris Inc. | 1.35% |
| 18 | NBIX | Neurocrine Biosciences, Inc. | 1.19% |
| 19 | ASND | Ascendis Pharma A/S | 1.17% |
| 20 | MEDP | Medpace Holdings, Inc. | 1.08% |
| 21 | JAZZ | Jazz Pharmaceuticals plc | 1.03% |
| 22 | BBIO | BridgeBio Pharma, Inc. | 0.99% |
| 23 | EXEL | Exelixis, Inc. | 0.97% |
| 24 | IONS | Ionis Pharmaceuticals, Inc. | 0.94% |
| 25 | AXSM | Axsome Therapeutics, Inc. | 0.88% |
| View LON:BTEC holdings | |||